Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3003531	s-amokige	u/ml (—)	54	55	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Urticaria

18.20

13.34

1.0

—

Urticaria and erythema

18.20

13.33

1.0

—

Oral corticosteroids

6.47

11.83

1.0

—

ILD medications: prednisolone, methylprednisolone, prednisone

6.15

10.12

1.0

—

Other complications of surgical and medical care, not elsewhere classified

26.06

9.80

1.0

—

Inflammatory bowel disease treatment related agents

5.59

9.33

1.0

—

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

24.05

8.90

1.0

—

Other and unspecified drugs and medicaments

20.06

8.46

1.0

—

ILD medications

5.17

8.19

1.0

—

Allergic urticaria

18.38

7.59

1.0

—

First line medication for Crohn's disease

4.63

6.32

1.1

1.0

—

Personal history of allergy to drugs, medicaments and biological substances

+∞

6.26

1.2

0.0

—

Complications of surgical and medical care, not elsewhere classified

4.11

6.08

1.0

—

Asthma, hospital admissions , main diagnosis only

3.81

5.35

1.0

—

Complications of medical and surgical care

4.95

4.83

1.0

—

Other special examinations and investigations of persons without complaint or reported diagnosis

6.75

4.57

1.0

—

Diseases of the skin and subcutaneous tissue

4.13

4.25

1.0

—

Asthma (diagnoses ohter than nonallergic)

3.19

3.87

1.0

—

Dermatitis and eczema

3.10

3.86

1.1

1.0

—

5.95

3.78

1.0

—

Other and unspecified urticaria

8.76

3.77

1.0

—

Obesity related asthma

8.75

3.77

1.0

—

Adverse effects, not elsewhere classified

6.67

3.67

1.0

—

Asthma/COPD (KELA code 203)

3.05

3.66

1.0

—

Certain infectious and parasitic diseases

3.21

3.56

1.0

—

Asthma (only as main-diagnosis)

3.58

3.54

1.0

—

Fever of other and unknown origin

4.68

3.44

1.0

—

Lumbar disc prolapse

4.79

3.42

1.0

1.1

—

Other and unspecified effects of external causes

5.72

3.34

1.0

—

Systemic connective tissue disorders

5.72

3.33

1.0

—

Asthma (only as main-diagnosis), excluding more controls

3.72

3.27

1.0

1.1

—

Other bacterial intestinal infections

8.58

3.26

1.0

—

Symptoms and signs involving the skin and subcutaneous tissue

3.56

3.20

1.0

—

Asthma-related infections

4.08

3.12

1.0

—

Asthma, hospital admission 2, infections

4.08

3.12

1.0

—

Asthma (mode)

3.31

3.12

1.0

—

ILD medications: immunosuppressive drugs

4.40

3.02

1.1

1.0

—

Oedema, not elsewhere classified

5.76

2.98

1.1

1.0

—

Spondylopathies

4.27

2.98

1.0

1.1

—

Dermatitis due to substances taken internally

10.02

2.98

1.0

—

Dermatographic urticaria

10.01

2.98

1.0

—

Spondylosis

5.02

2.95

1.0

1.1

—

Non-selective monoamine reuptake inhibitors

5.62

2.93

1.0

—

Disorders of lacrimal system

4.69

2.91

1.0

—

Other viral diseases

5.37

2.86

1.0

—

Infections of the skin and subcutaneous tissue

3.67

2.84

1.1

1.0

—

Allergic asthma (mode)

6.53

2.82

1.0

—

Allergic asthma (mode), excluding more controls

6.53

2.82

1.0

—

Examination and observation for other reasons

5.14

2.81

1.0

—

Other viral diseases

4.41

2.77

1.0

—

Other disorders of skin and subcutaneous tissue, not elsewhere classified

8.34

2.75

1.0

—

Obesity, other/unspecified

6.00

2.69

1.0

—

Disorders of skin appendages

4.21

2.67

1.0

—

Asthma, excluding more controls

3.13

2.65

1.0

1.1

—

Cholecystectomy

3.45

2.63

1.0

—

Disorders of eyelid, lacrimal system and orbit

3.04

2.63

1.1

1.0

—

Obesity

3.12

2.60

1.0

—

Obesity and other hyperalimentation

3.12

2.60

1.0

—

Enlarged lymph nodes

7.14

2.55

1.0

—

Other enthesopathies

5.46

2.54

1.0

—

Other nutritional deficiencies

3.05

2.53

1.0

—

Other systemic involvement of connective tissue (FG)

5.38

2.51

1.0

—

Asthma

3.00

2.50

1.0

—

Renal tubulo-interstitial diseases

2.79

2.48

1.0

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

2.60

2.47

1.1

1.0

—

Other disorders of lacrimal gland

4.38

2.47

1.0

—

Persons encountering health services for examination and investigation

4.46

2.47

1.0

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

3.35

2.37

1.0

—

Necrosis of pulp, including avohilmo

3.63

2.35

1.0

—

Other intervertebral disc disorders

3.01

2.34

1.0

—

Other systemic involvement of connective tissue

4.62

2.27

1.0

—

Implicit viral Sepsis

4.62

2.27

1.0

—

Other reaction to severe stress, and adjustment disorders

3.89

2.25

1.0

—

Other and unspecified dermatitis

3.33

2.17

1.0

—

All anxiety disorders

3.09

2.15

1.0

—

Viral infections characterized by skin and mucous membrane lesions

3.68

2.14

1.0

1.1

—

Hypertensive diseases (excluding secondary)

4.07

2.13

1.0

—

Diseases of oesophagus, stomach and duodenum

2.51

2.11

1.0

—

Anxiety (asthma-related co-morbidities)

3.03

2.09

1.0

—

Polyarthropathies

3.09

2.09

1.1

1.0

—

Dermatitis

3.19

2.08

1.0

—

Sequelae of external causes of morbidity and mortality

5.00

2.07

1.0

—

Abnormal findings on diagnostic imaging of lung

3.53

2.06

1.0

—

Dental operations

3.42

2.01

1.0

—

Malaise and fatigue

3.52

2.00

1.0

—

Asthma, including avohilmo

2.28

1.99

1.0

—

Sleep apnoea, including avohilmo

2.62

1.96

1.0

—

Other and unspecified anaemias

3.81

1.94

1.2

1.0

—

Acute upper respiratory infections of multiple and unspecified sites

2.65

1.94

1.0

—

Other anaemias

3.80

1.94

1.2

1.0

—

Cutaneous abscess, furuncle and carbuncle

4.55

1.94

1.2

1.0

—

Localized swelling, mass and lump of skin and subcutaneous tissue

4.55

1.94

1.0

—

Chronic rhinitis, nasopharyngitis and pharyngitis

4.55

1.94

1.0

—

Asthma-related pneumonia

4.54

1.93

1.0

—

Asthma, hospital admissions 3, pneumonia

4.54

1.93

1.0

—

Asthma-related pneumonia or sepsis

4.54

1.93

1.0

—

Other disorders of skin and subcutaneous tissue

2.76

1.92

1.0

—

Diarrhoea and gastroenteritis of presumed infectious origin

2.57

1.92

1.0

—

Acute sinusitis

3.24

1.89

1.0

—

Intestinal infectious diseases

2.28

1.89

1.0

—

Diarrhoea and gastroenteritis of presumed infectious origin

2.32

1.87

1.0

—

Chronic lower respiratory diseases

2.22

1.87

1.0

—

Diseases of oral cavity, salivary glands and jaws

3.17

1.87

1.0

—

Follow-up examination after treatment for conditions other than malignant neoplasms

4.73

1.86

1.0

—

Second line medication for Crohn's disease

2.86

1.86

1.1

1.0

—

L04AX Other immunosuppressants

2.86

1.86

1.1

1.0

—

Asthma, unspecified (mode), excluding more controls

3.27

1.85

1.0

1.1

—

Reimbursement for rheumatic diseases

2.85

1.85

1.0

—

Pregnancy hypertension

2.87

1.84

1.0

—

Symptoms and signs involving speech and voice

3.53

1.83

1.0

—

Melanocytic naevi

4.17

1.82

1.0

—

Hypertension, essential

3.02

1.82

1.0

—

Other bacterial diseases

2.38

1.81

1.1

1.0

—

Aplastic and other anaemias

3.49

1.80

1.2

1.0

—

Erysipelas

3.10

1.80

1.1

1.0

—

Rheumatoid arthritis

4.08

1.76

1.0

—

Asthma, unspecified (mode)

3.10

1.76

1.0

1.1

—

Acute tubulo-interstitial nephritis

2.76

1.76

1.0

—

Osteopathies and chondropathies

2.96

1.73

1.0

—

Benign paroxysmal vertigo

3.85

1.71

1.0

—

Acute upper respiratory infections

2.31

1.70

1.0

—

Pain in limb

2.57

1.68

1.0

—

Care involving use of rehabilitation procedures

2.63

1.67

1.0

—

Shoulder lesions

3.03

1.67

1.0

1.1

—

Atopic dermatitis

2.62

1.65

1.1

1.0

—

Intestinal infectious diseases

2.22

1.65

1.0

—

Other soft tissue disorders, not elsewhere classified

2.39

1.65

1.0

—

Neurotic, stress-related and somatoform disorders

2.33

1.64

1.0

—

Spinal stenosis

3.80

1.63

1.0

1.1

—

Anxiety disorders

2.32

1.63

1.0

—

Exposure to other specified factors

2.41

1.62

1.0

—

Bacterial infection, other or unspecified

2.82

1.62

1.1

1.0

—

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

3.57

1.61

1.0

—

Missing teeth due to accident, extraction or parodontitis

2.75

1.60

1.0

—

Any reimbursement code in KELA

2.82

1.58

1.0

—

Viral infections characterized by skin and mucous membrane lesions

2.24

1.58

1.0

—

Chronic sinusitis

3.00

1.58

1.0

1.1

—

Viral and other specified intestinal infections

3.45

1.56

1.0

—

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

2.48

1.56

1.0

—

Carpal tunnel syndrome

2.68

1.55

1.0

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

3.30

1.50

1.0

—

Conduction disorders

3.38

1.50

1.0

—

Certain infectious and parasitic diseases

2.50

1.48

1.0

—

Syncope and collapse

3.29

1.47

1.0

—

Disorders of vestibular function (Vertigo)

2.81

1.47

1.0

—

Anxiety disorders, excluding more controls

2.32

1.47

1.0

—

Obesity due to excess calories

2.73

1.43

1.0

—

Sleep apnoea

2.33

1.41

1.0

—

Cardiovascular diseases (excluding rheumatic etc)

2.30

1.40

1.0

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

2.26

1.37

1.0

—

Triptan medication for migraine, single purchase ok

2.26

1.37

1.0

—

Hypertensive diseases

2.66

1.37

1.0

—

Hypertension

2.66

1.37

1.0

—

Headache

2.43

1.37

1.0

—

Rheumatoid arthritis, including avohilmo

2.94

1.36

1.0

—

Gestational [pregnancy-induced] hypertension

2.94

1.35

1.0

—

Allergic rhinitis

2.91

1.34

1.0

—

Other anxiety disorders

2.60

1.34

1.0

—

Disorders of other endocrine glands

2.57

1.34

1.0

—

Pain in throat and chest

2.22

1.32

1.0

—

Diseases of the eye and adnexa

2.28

1.32

1.0

—

Injury, poisoning and certain other consequences of external causes

2.51

1.32

1.0

1.1

—

Sciatica+with lumbago

2.87

1.31

1.0

1.1

—

Cholelithiasis, broad definition with cholecystitis

2.16

1.31

1.0

—

Dyspnoea

2.14

1.31

1.0

—

Diseases of inner ear

2.52

1.31

1.0

—

Artrosis, including avohilmo

2.43

1.30

1.0

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

2.13

1.29

1.1

1.0

—

Pure hypercholesterolaemia

2.37

1.28

1.1

1.0

—

Bacterial infection, other or unspecified

2.48

1.27

1.2

1.0

—

Chronic apical periodontitis

2.01

1.25

1.0

—

Visual disturbances

2.40

1.24

1.0

—

Rotator cuff syndrome

2.76

1.22

1.0

1.1

—

Other diseases of urinary system

1.98

1.21

1.0

—

Complications predominantly related to the puerperium

2.63

1.21

1.0

—

Cystitis

2.04

1.21

1.0

—

Diseases of the respiratory system

2.23

1.20

1.0

—

Congenital malformations, deformations and chromosomal abnormalities

2.11

1.18

1.0

—

Disorders of synovium and tendon

2.58

1.17

1.0

1.1

—

Cholelithiasis

2.12

1.17

1.0

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

2.79

1.17

1.0

—

Diseases of pulp and periapical tissues and dental caries

2.16

1.16

1.0

—

Other diseases of lip and oral mucosa

2.50

1.15

1.0

—

Other disorders of urethra and urinary system

2.06

1.13

1.0

—

Arthropathies

1.99

1.10

1.0

—

Venous thromboembolism

2.41

1.10

1.0

—

Excluding asthma or asthma-COPD overlap

2.15

1.10

1.0

—

Other pulmonary diagnosis

2.15

1.10

1.0

—

COPD differential diagnosis

2.15

1.10

1.0

—

ILD differential diagnosis

2.15

1.10

1.0

—

All kidney diseases

1.93

1.09

1.0

—

Erysipelas

2.23

1.08

1.1

1.0

—

Disorders of conjunctiva

1.96

1.07

1.0

—

Vasomotor and allergic rhinitis

2.34

1.06

1.0

—

Codeine or tramadol medication

1.88

1.06

1.0

—

Conjunctivitis

1.98

1.04

1.0

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

1.96

1.03

1.1

1.0

—

Other bacterial diseases

1.95

1.03

1.1

1.0

—

Low back pain

2.09

1.03

1.0

—

Other heart diseases

2.33

1.01

1.0

—

Symptoms and signs involving the urinary system

2.05

1.01

1.0

—

Disorders of gallbladder, biliary tract and pancreas

1.89

1.00

1.0

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

1.93

0.99

1.1

1.0

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

0.00

0.99

0.0

1.0

—

Complications of procedures, not elsewhere classified

2.00

0.99

1.0

—

Cardiovascular diseases

1.86

0.98

1.0

—

Endocrine, nutritional and metabolic diseases

1.95

0.96

1.0

—

Depression

1.88

0.94

1.0

—

Opioids

1.92

0.94

1.0

—

Triptan medication for migraine, min. 3 purchases

1.91

0.93

1.0

—

Dental caries, including avohilmo

2.05

0.93

1.0

—

Abdominal and pelvic pain

1.84

0.92

1.0

—

Gastro-oesophageal reflux disease

2.16

0.91

1.0

—

Visual disturbances and blindness

2.14

0.91

1.0

—

Caries of enamel

1.85

0.91

1.0

—

Symptoms and signs involving the nervous and musculoskeletal systems

2.07

0.89

1.0

—

Inflammatory diseases of female pelvic organs

1.90

0.88

1.0

—

Arthrosis

2.06

0.87

1.0

—

Chronic periodontitis, including avohilmo

1.85

0.86

1.0

—

Periodontitis

1.84

0.86

1.0

—

External causes of morbidity and mortality

1.82

0.85

1.0

—

Gastrointestinal diseases

1.82

0.85

1.0

—

Metabolic disorders

1.81

0.84

1.1

1.0

—

1.78

0.84

1.0

—

Disease of hard tissues of teeth, NOS

2.38

0.79

1.0

—

All dysplastic lesions of the cervix uteri

0.00

0.79

0.0

1.0

—

All dysplastic lesions of the cervix uteri, vagina or vulva

0.00

0.79

0.0

1.0

—

Mood disorders, excluding more controls

1.79

0.78

1.0

—

Other external causes of accidental injury

1.79

0.78

1.0

—

Mood [affective] disorders

1.75

0.77

1.0

—

Any gastric operation

1.74

0.77

1.0

—

GASTRO-related operations

1.74

0.77

1.0

—

Mood disorders

1.75

0.77

1.0

—

Contact with and exposure to communicable diseases

0.00

0.77

0.0

1.0

—

Nerve, nerve root and plexus disorders

1.75

0.76

1.0

—

Polycystic ovarian syndrome, consortium definition

1.72

0.76

1.0

—

Cardiac arrhythmias

1.89

0.75

1.0

—

Disorders of lipoprotein metabolism and other lipidaemias

1.88

0.75

1.1

1.0

—

Implicit Sepsis

1.88

0.74

1.0

—

Sleep disorders (combined)

1.70

0.74

1.0

—

Antihypertensive medication - note that there are other indications

1.86

0.74

1.0

—

Benign neoplasms

1.65

0.74

1.1

1.0

—

Female infertility, cervical, vaginal, other or unspecified origin

2.03

0.73

1.0

—

Open wound of head

2.01

0.72

1.0

—

Other heart diseases, wide

1.62

0.72

1.0

—

2.00

0.72

1.0

—

Disorders of choroid and retina

1.78

0.72

1.0

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

1.59

0.71

1.1

1.0

—

Other functional intestinal disorders

1.93

0.70

1.0

—

Any mental disorder

1.67

0.70

1.0

—

Persons encountering health services for specific procedures and health care

1.65

0.70

1.0

—

Female infertility

1.90

0.69

1.0

—

Parasetamol

1.69

0.68

1.0

—

Implicit Sepsis

1.65

0.67

1.0

—

Hypothyroidism, strict autoimmune

1.64

0.67

1.1

1.0

—

Presence of other functional implants

1.82

0.66

1.0

—

Disorders of sclera, cornea, iris and ciliary body

1.79

0.66

1.0

—

Dentofacial anomalies [including malocclusion]

1.61

0.65

1.0

—

Gonarthrosis

1.78

0.64

1.0

—

General symptoms and signs

1.67

0.64

1.0

—

Codeine

1.67

0.64

1.0

—

Organic, including symptomatic, mental disorders

0.00

0.62

0.0

1.0

—

Dysplasia of cervi uteri

0.00

0.62

0.0

1.0

—

Other diseases of upper respiratory tract

1.59

0.61

1.0

—

Hypothyroidism, other/unspecified

1.59

0.61

1.1

1.0

—

Malignant neoplasm of digestive organs

0.00

0.61

0.0

1.0

—

Labour and delivery complicated by fetal stress [distress]

0.00

0.61

0.0

1.0

—

Constipation

1.58

0.61

1.1

1.0

—

Other antidepressants

1.58

0.61

1.0

—

Statin medication

1.78

0.59

1.0

—

Diseases of pulp and periapical tissues, including avohilmo

1.62

0.59

1.0

—

Irregular menses

1.75

0.58

1.0

—

Finngen Rheumatological endpoints

1.52

0.58

1.0

—

Other arrhythmias

1.74

0.58

1.0

—

Accidents

1.61

0.58

1.0

—

Leiomyoma of uterus

1.70

0.57

1.0

—

Soft tissue disorders

1.60

0.57

1.0

—

Bronchitis

1.57

0.56

1.0

—

Dizziness and giddiness

1.64

0.56

1.0

—

Congenital malformations, deformations and chromosomal abnormalities

1.63

0.55

1.0

—

Heart failure, not strict

1.63

0.55

1.0

—

Autoimmune diseases related-to ILD

1.53

0.48

1.0

—

Falls/tendency to fall

0.60

0.48

1.0

—

Condition for Implicit Sepsis (Organ dysfunction codes)

1.51

0.48

1.0

—

Dorsalgia

1.44

0.46

1.0

—

Caries of dentine, including avohilmo

1.43

0.46

1.0

—

Mycoses

1.38

0.44

1.0

—

Varicose veins

1.64

0.43

1.0

—

Excessive, frequent and irregular menstruation

1.61

0.43

1.0

—

Disorders of the thyroid gland

1.45

0.43

1.1

1.0

—

Postmenopausal bleeding

0.00

0.43

0.0

1.0

—

Other retinal disorders

1.62

0.43

1.0

—

Diseases of male genital organs

0.00

0.43

0.0

1.1

—

Supervision of high-risk pregnancy

0.00

0.43

0.0

1.0

—

Benzodiazepine use

1.41

0.42

1.0

—

Single spontaneous delivery

1.56

0.42

1.0

—

Delivery

1.55

0.42

1.0

—

Gonarthrosis [arthrosis of knee](FG)

1.53

0.42

1.0

—

Peripheral artery disease

0.00

0.41

0.0

1.0

—

Atherosclerosis, excluding cerebral and coronary sclerosis

0.00

0.41

0.0

1.0

—

Lower back pain or/and sciatica

1.37

0.41

1.0

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

1.36

0.41

1.0

—

Other neurological diseases

1.51

0.41

1.0

—

Internal derangement of knee

0.00

0.41

0.0

1.0

—

HSIL lesion of the cervix uteri

0.00

0.41

0.0

1.0

—

Schizophrenia or delusion

0.00

0.41

0.0

1.0

—

Schizophrenia, schizotypal and delusional disorders

0.00

0.41

0.0

1.0

—

Maternal care for other known or suspected fetal problems

0.00

0.41

0.0

1.0

—

Glaucoma suspect

0.00

0.41

0.0

1.0

—

Dementia, including avohilmo

0.00

0.40

0.0

1.0

—

HSIL lesion of the cervix uteri, vagina or vulva

0.00

0.40

0.0

1.0

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

1.47

0.40

1.0

—

Excessive attrition of teeth

1.47

0.40

1.0

—

Epilepsy

0.00

0.40

0.0

1.0

—

Premature rupture of membranes

0.00

0.40

0.0

1.0

—

Injuries to the thorax

0.00

0.39

0.0

1.1

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1.32

0.38

1.0

—

Influenza and pneumonia

1.30

0.37

1.0

—

Diseases of the musculoskeletal system and connective tissue

1.43

0.36

1.0

—

Genitourinary diseases

1.43

0.36

1.0

—

Injuries to the head

1.40

0.35

1.0

—

Appendicitis, broad definition

1.39

0.35

1.0

—

Pain (limb, back, neck, head abdominally)

1.37

0.35

1.0

—

Diseases of appendix

1.39

0.35

1.0

—

Condition for Implicit Sepsis (Organ dysfunction codes)

1.32

0.33

1.0

—

Other dorsopathies, not elsewhere classified

1.41

0.32

1.0

—

Selective serotonin reuptake inhibitors

1.41

0.32

1.0

—

Neoplasms

1.37

0.32

1.0

—

Pneumonia, organism unspecified

1.33

0.31

1.0

—

Abnormalities of breathing

1.27

0.30

1.0

—

Behavioural syndromes associated with physiological disturbances and physical factors

1.27

0.30

1.0

—

Symptoms and signs involving the digestive system and abdomen

1.34

0.29

1.0

—

Psychiatric diseases

1.29

0.29

1.0

—

COPD/asthma/ILD related infections

1.29

0.29

1.0

—

COPD/asthma related infections

1.29

0.29

1.0

—

Pneumonias (Asthma/COPD co-morbidities)

1.28

0.28

1.0

—

All pneumoniae

1.27

0.28

1.0

—

Use of hypnotics and sedatives

1.24

0.27

1.0

—

Persons encountering health services in other circumstances, wide

1.25

0.26

1.0

—

Noninflammatory disorders of female genital tract

1.39

0.24

1.0

—

Depression or dysthymia

1.38

0.24

1.0

1.1

—

Allergic conjunctivitis

1.32

0.23

1.0

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

1.28

0.23

1.0

—

Acute appendicitis

1.26

0.22

1.0

—

Gonarthrosis,primary

1.23

0.22

1.0

—

Bleeding

1.23

0.22

1.0

—

Single delivery by forceps and vacuum extractor

0.00

0.22

0.0

1.0

—

Any dementia

0.00

0.22

0.0

1.0

—

Unspecific neurodegenerative disorder

0.00

0.22

0.0

1.0

—

Status post-ami

0.00

0.22

0.0

1.0

—

Outcome of delivery

0.00

0.21

0.0

1.0

—

Malignant neoplasm of respiratory system and intrathoracic organs

0.00

0.21

0.0

1.0

—

Malignant neoplasm of bronchus and lung, including Hilmo

0.00

0.21

0.0

1.0

—

Other degenerative diseases of the nervous system

0.00

0.21

0.0

1.0

—

Single delivery by caesarean section

0.00

0.21

0.0

1.0

—

Congenital malformations and deformations of the musculoskeletal system

0.00

0.21

0.0

1.0

—

Focal epilepsy

0.00

0.21

0.0

1.0

—

LSIL lesion of the cervix uteri

0.00

0.21

0.0

1.0

—

Focal epilepsy, mode (most common among epilepsy diagnosis)

0.00

0.21

0.0

1.0

—

Focal epilepsy, strict definition

0.00

0.21

0.0

1.0

—

Postpartum haemorrhage due to retained placenta

0.00

0.21

0.0

1.0

—

Obstructed labour due to maternal pelvic abnormality

0.00

0.21

0.0

1.0

—

L02BA Anti-estrogens

0.00

0.21

0.0

1.0

—

Pediculosis, acariasis and other infestations

0.00

0.21

0.0

1.0

—

Benign neoplasm of other and ill-defined parts of digestive system

0.00

0.21

0.0

1.0

—

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

0.00

0.21

0.0

1.0

—

Other and unspecified nerve root and plexus disorders, also in other diseases

0.00

0.21

0.0

1.0

—

Other and unspecified nonorganic psychotic disorders

0.00

0.21

0.0

1.0

—

Superficial injury of wrist and hand

0.00

0.21

0.0

1.0

—

Pedal cyclist injured in transport accident

0.00

0.21

0.0

1.0

—

Tinnitus

0.00

0.21

0.0

1.0

—

Effects of foreign body entering through natural orifice

0.00

0.21

0.0

1.0

—

Blepharochalasis

0.00

0.21

0.0

1.0

—

Colorectal cancer

0.00

0.21

0.0

1.0

—

Other problems related to primary support group, including family circumstances

0.00

0.21

0.0

1.0

—

Sulfonylureas

0.00

0.21

0.0

1.0

—

Other noninflammatory disorders of uterus, except cervix

0.00

0.21

0.0

1.0

—

Other complications of labour and delivery, not elsewhere classified

0.00

0.21

0.0

1.0

—

LSIL lesion of the cervix uteri, vagina or vulva

0.00

0.21

0.0

1.0

—

Other fall from one level to another

0.00

0.21

0.0

1.0

—

malignant neoplasm of female genital organs

0.00

0.21

0.0

1.0

—

Schizophrenia or delusion, excluding more controls

0.00

0.21

0.0

1.0

—

Otitis media, unspecified

0.00

0.21

0.0

1.0

—

Heart failure and coronary heart disease

0.00

0.21

0.0

1.0

—

Ectopic pregnancy

0.00

0.21

0.0

1.0

—

Otitis externa

0.00

0.21

0.0

1.0

—

Calculus of kidney and ureter

0.00

0.21

0.0

1.0

—

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

0.00

0.20

0.0

1.0

—

Deep bite

0.00

0.20

0.0

1.0

—

Dementia

0.00

0.20

0.0

1.0

—

Combinations of oral blood glucose lowering drugs

0.00

0.20

0.0

1.0

—

Umbilical hernia

0.00

0.20

0.0

1.1

—

Fracture of rib(s), sternum and thoracic spine

0.00

0.20

0.0

1.0

—

Retinal detachments and breaks

0.00

0.20

0.0

1.0

—

Urolithiasis

0.00

0.20

0.0

1.0

—

Nausea and vomiting

0.00

0.20

0.0

1.0

—

Complications of labour and delivery

1.19

0.20

1.0

—

Insomnia

1.18

0.19

1.0

—

1.17

0.19

1.0

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1.17

0.19

1.0

—

Sleep disorders

1.17

0.19

1.0

—

Chronic diseases of tonsils and adenoids

1.15

0.19

1.0

—

Gingivitis and periodontal diseases

1.20

0.18

1.0

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

1.22

0.18

1.0

—

Episodal and paroxysmal disorders

0.71

0.17

1.0

—

Diabetes, varying definitions

0.73

0.17

1.0

—

Diabetes mellitus

0.73

0.17

1.0

—

Exposure to unspecified factor

0.73

0.17

1.0

—

Autoimmune diseases

1.13

0.16

1.1

1.0

—

Injuries to the shoulder and upper arm

1.15

0.10

1.0

—

Malignant neoplasm

1.06

0.09

1.2

1.0

—

Other maternal disorders predominantly related to pregnancy

1.04

0.09

1.0

—

Neurological diseases

0.78

0.08

1.0

—

Any event in cancer register

0.77

0.08

1.2

1.0

—

Symptoms and signs involving the circulatory and respiratory systems

1.10

0.08

1.0

—

Injuries to the wrist and hand

1.08

0.08

1.0

—

Injuries to the knee and lower leg

1.03

0.07

1.0

—

Antepartum haemorrhage, not elsewhere classified

0.00

0.0

1.0

—

Mental retardation, wide definition

0.00

0.0

1.0

—

Congenital malformations of eye, ear, face and neck

0.00

0.0

1.0

—

Type 1 diabetes, definitions combined

0.00

0.0

1.0

—

Retinal breaks without detachment

0.00

0.0

1.0

—

Brachial plexus disorders

0.00

0.0

1.0

—

Emotional disorders starting during childhood or adolescence

0.00

0.0

1.0

—

Other peripheral vascular diseases

0.00

0.0

1.0

—

Dystonia

0.00

0.0

1.0

—

Complications following abortion and ectopic and molar pregnancy

0.00

0.0

1.0

—

Disorders of optic nerve and visual pathways

0.00

0.0

1.0

—

Other noninflammatory disorders of cervix uteri

0.00

0.0

1.0

—

Female infertility, associated with anovulation

0.00

0.0

1.0

—

Malignant neoplasm of rectum, including Hilmo

0.00

0.0

1.0

—

Problems related to lifestyle

0.00

0.0

1.0

—

Family history of malignant neoplasm

0.00

0.0

1.0

—

Mandibular retrognathia

0.00

0.0

1.0

—

Colon adenocarcinoma

0.00

0.0

1.0

—

Pedal cyclist injured in noncollision transport accidents

0.00

0.0

1.0

—

Fall on same level

0.99

0.00

1.0

—

L04AC Interleukin inhibitors

0.00

0.0

1.0

—

Nephropathy related operations

0.00

0.0

1.0

—

L04AD Calcineurin inhibitors

0.00

0.0

1.0

—

Other diseases of intestines

0.99

0.00

1.1

1.0

—

Autoimmune diseases excluding thyroid diseases

0.96

0.00

1.0

—

KRA_PSY_EATING, excluding more controls

0.00

0.0

1.0

—

Benign neoplasm: Colon, unspecified

0.00

0.0

1.0

—

Benign neoplasm: Caecum

0.00

0.0

1.0

—

Other peripheral vertigo

0.00

0.0

1.0

—

Other diseases of oesophagus

0.00

0.0

1.0

—

Schizophrenia

0.00

0.0

1.0

—

COPD, hospital admissions 3, with asthma pneumonia sepsis

0.00

0.0

1.0

—

Hypermetropia

0.00

0.0

1.0

—

Trigeminal neuralgia

0.00

0.0

1.0

—

Infections of genitourinary tract in pregnancy

0.00

0.0

1.0

—

Alcohol dependence

0.00

0.0

1.0

—

Bell's palsy

0.00

0.0

1.0

—

Injury of eye and orbit

0.00

-0.00

0.0

1.0

—

Dislocation, sprain and strain of joints and ligaments at neck level

0.00

-0.00

0.0

1.0

—

Benign neoplasm of brain and other parts of central nervous system

0.00

-0.00

0.0

1.0

—

Contusion of other and unspecified parts of foot

0.00

-0.00

0.0

1.0

—

Congenital malformations of the urinary system

0.00

-0.00

0.0

1.0

—

Foreign body on external eye

0.00

-0.00

0.0

1.0

—

Superficial injury of forearm

0.00

-0.00

0.0

1.0

—

Superficial injury of thorax

0.00

-0.00

0.0

1.0

—

Sequelae of injuries of lower limb

0.00

-0.00

0.0

1.0

—

Aneurysms, operations, SAH

0.00

-0.00

0.0

1.0

—

Dental pulpitis, including avohilmo

0.85

-0.00

1.0

—

Nontraumatic intracranial haemmorrhage

0.00

-0.00

0.0

1.0

—

Other diseases of the respiratory system

0.00

-0.00

0.0

1.0

—

Abnormal results of function studies

0.00

-0.00

0.0

1.0

—

Aortic aneurysm

0.00

-0.00

0.0

1.0

—

Non-small cell lung cancer, including Hilmo

0.00

-0.00

0.0

1.0

—

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

0.00

-0.00

0.0

1.0

—

Elevated blood glucose level

0.00

-0.00

0.0

1.0

—

Non-Hodgkin lymphoma, all, including Hilmo

0.00

-0.00

0.0

1.0

—

Follow-up care involving plastic surgery

0.00

-0.00

0.0

1.0

—

N06DA Anticholinesterases

0.00

-0.00

0.0

1.0

—

Atrial septal defect, secundum type

0.00

-0.00

0.0

1.0

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Amoxicillin IgE Ab [Units/volume] in Serum

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS